Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

But a pair of treatments that launched in 2019 are already offsetting Humira's losses. Combined sales of Skyrizi, a psoriasis ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD) as the market for ...

Skyrizi was the top Rx and over-the-counter (OTC) pharma brand advertising on TV in 2024, according to data released by iSpot.tv on Thursday afternoon. AbbVie’s psoriasis, ulcerative colitis, Crohn’s ...

The catalyst for the rebound has been Bimzelx, which was approved for plaque psoriasis in October of ... 12:55 p.m. ET The remarkable success of Skyrizi and Rinvoq has allowed AbbVie to accomplish ...

A few treatments are known to help clear psoriasis symptoms fast, such as Clobex spray, cyclosporine, and Humria. When choosing a psoriasis treatment, however, also consider other factors like side ...

Send your kids to these sites to help them learn, study, indulge their curiosity, and get a fresh perspective on academic subjects. I've been contributing to PCMag since 2011 in a variety of ways ...